Vitamin B-6, Independent of Homocysteine, Is a Significant Factor in Relation to Inflammatory Responses for Chronic Kidney Disease and Hemodialysis Patients

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2017 Oct 31

PMID 29082255

Citations 5

Authors

Cheng-Hsu Chen

En-Ling Yeh

Chih-Chung Chen

Shih-Chien Huang

Yi-Chia Huang

Affiliations

Soon will be listed here.

Abstract

The purpose of this study was to investigate whether plasma pyridoxal 5'-phosphate (PLP) and homocysteine were dependent on or independent of each other in order to be associated with inflammatory markers in patients with chronic kidney disease (CKD) or those receiving hemodialysis treatment. This was a cross-sectional study. Sixty-eight stage 2-5 CKD patients and 68 hemodialysis patients had one time fasting blood drawn for measurements of plasma PLP, pyridoxal (PL), homocysteine, and several inflammatory markers. Early CKD stage (stages 2-3) patients showed significantly lower plasma PLP levels and homocysteine concentrations than patients in an advanced CKD stage (stages 4-5) and those undergoing hemodialysis. Plasma PLP significantly correlated with CRP levels (partial = -0.21, < 0.05) and plasma PL significantly correlated with IL-10 levels (partial = -0.24, < 0.01), while plasma PLP plus PL significantly correlated with both CRP levels (partial = -0.20, < 0.05) and interleukin-1 (partial = 0.22, < 0.05) levels after adjusting for plasma homocysteine and other potential confounders. Plasma homocysteine displayed no significant correlations with any inflammatory markers. Vitamin B-6 status, rather than homocysteine, appeared to be a significant factor in relation to inflammatory responses for CKD and hemodialysis patients.

Citing Articles

Physiological Associations between Vitamin B Deficiency and Diabetic Kidney Disease.

Wu H, McDonnell T, Chinnadurai R Biomedicines. 2023; 11(4).

PMID: 37189771 PMC: 10135933. DOI: 10.3390/biomedicines11041153.

Follicular Fluid: A Powerful Tool for the Understanding and Diagnosis of Polycystic Ovary Syndrome.

Brinca A, Ramalhinho A, Sousa A, Oliani A, Breitenfeld L, Passarinha L Biomedicines. 2022; 10(6).

PMID: 35740276 PMC: 9219683. DOI: 10.3390/biomedicines10061254.

The weak correlation between serum vitamin levels and chronic kidney disease in hospitalized patients: a cross-sectional study.

Wang Y, Zheng Y, Chen P, Liang S, He P, Shao X BMC Nephrol. 2021; 22(1):292.

PMID: 34445968 PMC: 8393712. DOI: 10.1186/s12882-021-02498-5.

Circulatory and Urinary B-Vitamin Responses to Multivitamin Supplement Ingestion Differ between Older and Younger Adults.

Sharma P, Han S, Gillies N, Thorstensen E, Goy M, Barnett M Nutrients. 2020; 12(11).

PMID: 33212933 PMC: 7698360. DOI: 10.3390/nu12113529.

Network analysis of membranous glomerulonephritis based on metabolomics data.

Taherkhani A, Kalantari S, Arefi Oskouie A, Nafar M, Taghizadeh M, Tabar K Mol Med Rep. 2018; 18(5):4197-4212.

PMID: 30221719 PMC: 6172390. DOI: 10.3892/mmr.2018.9477.

References

Friso S, Jacques P, Wilson P, Rosenberg I, Selhub J . Low circulating vitamin B(6) is associated with elevation of the inflammation marker C-reactive protein independently of plasma homocysteine levels. Circulation. 2001; 103(23):2788-91. DOI: 10.1161/01.cir.103.23.2788. View

Friedman A, Bostom A, Selhub J, Levey A, Rosenberg I . The kidney and homocysteine metabolism. J Am Soc Nephrol. 2001; 12(10):2181-2189. DOI: 10.1681/ASN.V12102181. View

Suliman M, Lindholm B, Barany P, Bergstrom J . Hyperhomocysteinemia in chronic renal failure patients: relation to nutritional status and cardiovascular disease. Clin Chem Lab Med. 2001; 39(8):734-8. DOI: 10.1515/CCLM.2001.122. View

Coburn S, Reynolds R, Mahuren J, Schaltenbrand W, Wang Y, Ericson K . Elevated plasma 4-pyridoxic acid in renal insufficiency. Am J Clin Nutr. 2002; 75(1):57-64. DOI: 10.1093/ajcn/75.1.57. View

Talwar D, Quasim T, McMillan D, Kinsella J, Williamson C, OReilly D . Pyridoxal phosphate decreases in plasma but not erythrocytes during systemic inflammatory response. Clin Chem. 2003; 49(3):515-8. DOI: 10.1373/49.3.515. View

Talwar D, Quasim T, McMillan D, Kinsella J, Williamson C, OReilly D . Optimisation and validation of a sensitive high-performance liquid chromatography assay for routine measurement of pyridoxal 5-phosphate in human plasma and red cells using pre-column semicarbazide derivatisation. J Chromatogr B Analyt Technol Biomed Life Sci. 2003; 792(2):333-43. DOI: 10.1016/s1570-0232(03)00320-9. View

Kelly P, Kistler J, Shih V, Mandell R, Atassi N, Barron M . Inflammation, homocysteine, and vitamin B6 status after ischemic stroke. Stroke. 2003; 35(1):12-5. DOI: 10.1161/01.STR.0000106481.59944.2F. View

Friedman A, Hunsicker L, Selhub J, Bostom A . Clinical and nutritional correlates of C-reactive protein in type 2 diabetic nephropathy. Atherosclerosis. 2004; 172(1):121-5. DOI: 10.1016/j.atherosclerosis.2003.09.011. View

Eustace J, Astor B, Muntner P, Ikizler T, Coresh J . Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney Int. 2004; 65(3):1031-40. DOI: 10.1111/j.1523-1755.2004.00481.x. View

10.

Mansoor M, Seljeflot I, Arnesen H, Knudsen A, Bates C, Mishra G . Endothelial cell adhesion molecules in healthy adults during acute hyperhomocysteinemia and mild hypertriglyceridemia. Clin Biochem. 2004; 37(5):408-14. DOI: 10.1016/j.clinbiochem.2004.01.003. View

11.

Rao M, Guo D, Perianayagam M, Tighiouart H, Jaber B, Pereira B . Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis. 2005; 45(2):324-33. DOI: 10.1053/j.ajkd.2004.09.018. View

12.

Gori A, Corsi A, Fedi S, Gazzini A, Sofi F, Bartali B . A proinflammatory state is associated with hyperhomocysteinemia in the elderly. Am J Clin Nutr. 2005; 82(2):335-41. DOI: 10.1093/ajcn.82.2.335. View

13.

Li M, Chen J, Li Y, Feng Y, Gu X, Shi C . Folic acid reduces adhesion molecules VCAM-1 expession in aortic of rats with hyperhomocysteinemia. Int J Cardiol. 2005; 106(2):285-8. DOI: 10.1016/j.ijcard.2005.07.006. View

14.

Chiang E, Smith D, Selhub J, Dallal G, Wang Y, Roubenoff R . Inflammation causes tissue-specific depletion of vitamin B6. Arthritis Res Ther. 2005; 7(6):R1254-62. PMC: 1297572. DOI: 10.1186/ar1821. View

15.

Peeters A, van Aken B, Blom H, Reitsma P, den Heijer M . The effect of homocysteine reduction by B-vitamin supplementation on inflammatory markers. Clin Chem Lab Med. 2007; 45(1):54-8. DOI: 10.1515/CCLM.2007.021. View

16.

Cianciolo G, La Manna G, Coli L, Donati G, DAddio F, Persici E . 5-methyltetrahydrofolate administration is associated with prolonged survival and reduced inflammation in ESRD patients. Am J Nephrol. 2008; 28(6):941-8. PMC: 2786016. DOI: 10.1159/000142363. View

17.

van den Kommer T, Dik M, Comijs H, Jonker C, Deeg D . Homocysteine and inflammation: predictors of cognitive decline in older persons?. Neurobiol Aging. 2008; 31(10):1700-9. DOI: 10.1016/j.neurobiolaging.2008.09.009. View

18.

Picotte M, Campbell C, Thorland W . Day-to-day variation in plasma interleukin-6 concentrations in older adults. Cytokine. 2009; 47(3):162-5. DOI: 10.1016/j.cyto.2009.05.007. View

19.

Busch M, Gobert A, Franke S, Ott U, Gerth J, Muller A . Vitamin B6 metabolism in chronic kidney disease--relation to transsulfuration, advanced glycation and cardiovascular disease. Nephron Clin Pract. 2009; 114(1):c38-46. DOI: 10.1159/000245068. View

20.

Carrero J, Stenvinkel P . Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal. Clin J Am Soc Nephrol. 2009; 4 Suppl 1:S49-55. DOI: 10.2215/CJN.02720409. View